The Role of N⁶-Methyladenosine Modification in Microvascular Dysfunction

Area of Science:

• Epigenetics
• Molecular Biology
• Vascular Biology

Background:

• Microvascular dysfunction (MVD) is a significant health issue, increasing with age and leading to organ damage and complications.
• Current understanding of MVD's molecular mechanisms is insufficient for developing effective therapies.
• Epigenetic modifications, particularly RNA methylation, are emerging as key regulators of vascular events.

Purpose of the Study:

• To review the interaction between N⁶-methylation of adenosine (m⁶A) and microvascular dysfunction (MVD).
• To examine alterations in the m⁶A regulatory network in pathological conditions.
• To highlight the potential of m⁶A regulators as biomarkers and therapeutic targets for MVD.

Main Methods:

• Literature review of recent advances in epigenetics and vascular biology.
• Analysis of the role of m⁶A modification in regulating vascular transcripts.
• Discussion of pathological conditions associated with m⁶A network disruption.

Main Results:

• m⁶A is the most prevalent RNA modification, crucial for maintaining microvascular homeostasis by regulating vascular transcripts.
• Disruption of the m⁶A regulatory network is linked to the development of MVD.
• Alterations in m⁶A regulators are observed under various pathological conditions.

Conclusions:

• m⁶A methylation is a critical epigenetic mechanism involved in MVD.
• m⁶A regulators show promise as prognostic biomarkers for MVD.
• Targeting the m⁶A network offers a novel therapeutic strategy for MVD.